Jacobson Pharma, JBM Renew Logistics, Manufacturing Agreements

MT Newswires Live
03/09

Jacobson Pharma (HKG:2633) and JBM (Healthcare) (HKG:2161) renewed logistics and manufacturing services agreements for three years from April 1, 2026, to March 31, 2029, according to a March 6 joint Hong Kong bourse filing.

Under the agreements, the Jacobson group will continue providing logistics services to the JBM group, while the JBM group will provide manufacturing services for certain generic drugs to Jacobson.

Annual caps for the logistics services are set at HK$8 million for the year ending March 2027, HK$9 million for 2028, and HK$10 million for 2029.

Caps for the manufacturing services are HK$7 million, HK$8 million, and HK$9 million for the respective years, the filing said.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10